MedVital, a MedTech startup focused on advanced wound healing and minimally invasive aesthetics, has raised Rs 8.4 crore in a pre-seed funding round led by Nihar Parikh’s 4point0 Health Ventures. The round also saw participation from prominent healthcare and logistics entrepreneurs, including the founders of Tata 1mg, NephroPlus, SafeExpress, Eye Q Hospital, Hexa Health, and AstroTalk.
Amid rising cases of chronic wounds due to diabetes, obesity, trauma, and an increasing demand for non-invasive cosmetic treatments, MedVital is addressing a critical gap in accessible, outcome-driven skin repair and restoration technologies. Its flagship product, NoWound, is a compact, digitally enabled, and Made-in-India Negative Pressure Wound Therapy (NPWT) device designed for use in hospitals, clinics, and home-care settings, even in low-resource environments.
"MedVital was founded on the belief that skin repair and restoration deserve the same level of innovation as any other medical field,” said Dr. Varun Gupta, Co-Founder and CEO. “We’re building a platform that combines clinically validated devices, intelligent monitoring, and biomaterials to treat complex wounds and restore patient confidence.”
The funding will help MedVital expand its product portfolio, strengthen its supply chain, and extend distribution to tertiary hospitals, rural health centres, and home-based care. The company plans to launch liquid chitosan-based wound dressings and enter dermal and hair regeneration segments in the coming months.
Co-Founder and COO Tarun Bansal stated, “Our goal is to position India as a global leader in advanced wound care. This funding fuels our mission to deliver practical solutions that work not just in ICUs, but across the entire healthcare ecosystem.”
Investor Nihar Parikh added, “MedVital’s integrated approach to chronic wound care and aesthetics aligns with our vision of backing companies solving India’s healthcare challenges through innovation and impact. Their model combines clinical rigour with accessibility—a rare and powerful combination.”
Source: bwhealthcareworld
#healthcarestartupfundingindia #dseidehealthcarenetwork
Amid rising cases of chronic wounds due to diabetes, obesity, trauma, and an increasing demand for non-invasive cosmetic treatments, MedVital is addressing a critical gap in accessible, outcome-driven skin repair and restoration technologies. Its flagship product, NoWound, is a compact, digitally enabled, and Made-in-India Negative Pressure Wound Therapy (NPWT) device designed for use in hospitals, clinics, and home-care settings, even in low-resource environments.
"MedVital was founded on the belief that skin repair and restoration deserve the same level of innovation as any other medical field,” said Dr. Varun Gupta, Co-Founder and CEO. “We’re building a platform that combines clinically validated devices, intelligent monitoring, and biomaterials to treat complex wounds and restore patient confidence.”
The funding will help MedVital expand its product portfolio, strengthen its supply chain, and extend distribution to tertiary hospitals, rural health centres, and home-based care. The company plans to launch liquid chitosan-based wound dressings and enter dermal and hair regeneration segments in the coming months.
Co-Founder and COO Tarun Bansal stated, “Our goal is to position India as a global leader in advanced wound care. This funding fuels our mission to deliver practical solutions that work not just in ICUs, but across the entire healthcare ecosystem.”
Investor Nihar Parikh added, “MedVital’s integrated approach to chronic wound care and aesthetics aligns with our vision of backing companies solving India’s healthcare challenges through innovation and impact. Their model combines clinical rigour with accessibility—a rare and powerful combination.”
Source: bwhealthcareworld
#healthcarestartupfundingindia #dseidehealthcarenetwork
MedVital, a MedTech startup focused on advanced wound healing and minimally invasive aesthetics, has raised Rs 8.4 crore in a pre-seed funding round led by Nihar Parikh’s 4point0 Health Ventures. The round also saw participation from prominent healthcare and logistics entrepreneurs, including the founders of Tata 1mg, NephroPlus, SafeExpress, Eye Q Hospital, Hexa Health, and AstroTalk.
Amid rising cases of chronic wounds due to diabetes, obesity, trauma, and an increasing demand for non-invasive cosmetic treatments, MedVital is addressing a critical gap in accessible, outcome-driven skin repair and restoration technologies. Its flagship product, NoWound, is a compact, digitally enabled, and Made-in-India Negative Pressure Wound Therapy (NPWT) device designed for use in hospitals, clinics, and home-care settings, even in low-resource environments.
"MedVital was founded on the belief that skin repair and restoration deserve the same level of innovation as any other medical field,” said Dr. Varun Gupta, Co-Founder and CEO. “We’re building a platform that combines clinically validated devices, intelligent monitoring, and biomaterials to treat complex wounds and restore patient confidence.”
The funding will help MedVital expand its product portfolio, strengthen its supply chain, and extend distribution to tertiary hospitals, rural health centres, and home-based care. The company plans to launch liquid chitosan-based wound dressings and enter dermal and hair regeneration segments in the coming months.
Co-Founder and COO Tarun Bansal stated, “Our goal is to position India as a global leader in advanced wound care. This funding fuels our mission to deliver practical solutions that work not just in ICUs, but across the entire healthcare ecosystem.”
Investor Nihar Parikh added, “MedVital’s integrated approach to chronic wound care and aesthetics aligns with our vision of backing companies solving India’s healthcare challenges through innovation and impact. Their model combines clinical rigour with accessibility—a rare and powerful combination.”
Source: bwhealthcareworld
#healthcarestartupfundingindia #dseidehealthcarenetwork
